Reeve Emma sold PTCT
January 5, 2026 · Form 4 insider transaction
Reeve Emma sold 734 shares of PTC Therapeutics, Inc. at $76.00 per share, a transaction worth $55.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
734
Price
$76.00
Total value
$55.8K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after10,666
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.